Olaparib
SHARE
Molecule Summary
| Uses | Ovarian cancer, Breast cancer, Fallopian Tube Cancer |
| Therapy | Anti-Neoplastic |
| Side Effects | Anaemia, Loss of appetite, Dizziness, Headache, Cough, Fatigue, Vomiting, Diarrhoea, Nausea |
Medicines
available
19k pincodes
Molecule Description
Olaparib is an anti-cancer medicine. It works by disrupting a key repair mechanism in cancer cells, making it difficult for them to repair their damaged DNA and leading to their inability to grow and spread. This targeted approach helps in the treatment of certain types of cancer, particularly those with defects in DNA repair pathways.
Women of childbearing potential should not be pregnant when starting treatment with Olaparib, and they should use effective contraception throughout the course of therapy and for 6 months after the last dose. Before initiating treatment, a pregnancy test is recommended for all women capable of becoming pregnant.
These precautions are necessary to prevent unintended pregnancies and ensure the safety of both the woman and potential fetus, as Olaparib may pose risks to fetal development. Therefore, strict adherence to reliable contraception methods is crucial for women of childbearing potential receiving Olaparib.
Uses
- Ovarian cancer
- Breast cancer
- Fallopian Tube Cancer
Contraindications
When should one not use Olaparib
- Allergy to the active substance or any of the excipients of Olaparib
- Pregnancy
Side effects
Common side effects of this drug are:
- Anaemia
- Loss of appetite
- Dizziness
- Headache
- Dysgeusia (altered taste )
- Cough
- Fatigue
- Vomiting
- Diarrhoea
- Nausea
- Indigestion and heartburn
- Low WBC and platelets
Precautions and Warnings
Pregnancy
Driving
Alcohol
Other General Warnings
Talk to your doctor if
- You have liver or kidney problems.
- You are taking any other medications or herbal supplements.
- You are pregnant, become pregnant, or plan to become pregnant. Olaparib can harm an unborn baby and may cause loss of pregnancy (miscarriage).
- You are breastfeeding or plan to breastfeed.
- Females who can become pregnant should use effective birth control (contraception) during treatment with Olaparib and for 6 months after the last dose of Olaparib.
- Males with female partners who are pregnant or able to become pregnant should use effective birth control (contraception) during treatment with Olaparib and for 3 months after the last dose.
- Do not donate sperm during treatment and for 3 months after your last dose.
- Do not breastfeed during treatment and for 1 month after receiving the last dose.
Mode of Action
How Does It Work?
Olaparib disrupts a key repair mechanism in cancer cells, making it difficult for them to repair their damaged DNA and leading to their inability to grow and spread. This targeted approach helps in the treatment of certain types of cancer, particularly those with defects in DNA repair pathways. This medicine is usually prescribed as adjunctive therapy in cancer treatment.
Interactions
Interactions with food items
Grapefruit or grapefruit juice should not be taken while on this medicine.
Dosage
Overdose
In the event of an overdose, report to your doctor immediately.
Missed a Dose
Report to your doctor immediately. Do not take extra doses to compensate for missed doses.
Frequently Asked Questions (FAQs)
Articles
View AllDid you find this helpful?
References:
Explore More at Pharmeasy
Why trust PharmEasy?
# ONE OF INDIA'S MOST TRUSTED HEALTHCARE PLATFORM
CODAvailable
100%Genuine Medicine
30 DAYReturn Policy









